Increase in global government initiatives, and the expansion of genetic database creation, is expected to drive market expansion in the near future at a CAGR of 7.20% during the forecast period 2023 to 2032.

Market Research Future (MRFR) has published a “Global Personalized Medicine Market”

Market Highlights

The global personalized medicine market is accounted to register a CAGR of 7.20% during the forecast period and is estimated to reach USD 970.7 billion by 2032.

Personalized Medicine is type of treatment known as personalized medicine focuses on the distinctive physiological traits of each patient. With an emphasis on sickness comprehension and management using advanced analytics, customized medications, patient data, and other choices, personalized medicine has a huge potential to change and adapt the healthcare industry.

The development of effective and cutting-edge technology, rising levels of public awareness of personalized medicine, an increase in global government initiatives, and the expansion of genetic database creation are the main growth drivers of the worldwide personalized medicine market.  

Key Players

MRFR recognizes the following companies as the key players in the global personalized medicine market— Illumina Inc., Precision Biologics, Danaher Corporation, GE Healthcare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., and Biogen

Segment Analysis

The global personalized medicine market has been segmented based product, application and end-user.

On the basis of product, the market is segmented into personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition and wellness. The personalized nutrition and wellness segment was attributed to holding the largest market share in 2022.

Based on application, the global personalized medicine market has been segmented into oncology, CNS, immunology, respiratory, and others. The oncology segment was expected to hold the largest market share in 2022.

Based on end-user, the global personalized medicine market has been segmented into hospitals, diagnostic centers, research & academic institutes, and others. The hospitals segment was expected to hold the largest market share in 2022.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Personalized Medicine Market Research Report

Regional Analysis

The global personalized medicine market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Personalized medicine market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Personalized medicine market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Personalized medicine market comprises of Middle East, Africa, and Latin America.

The largest market share for personalized medicine was maintained by the North American regional sector. The largest portion—more than 45.80%—belonged to North America in 2022. Funding from significant pharmaceutical corporations and research institutions is related to this. Personalized medicine is now the most effective way to treat all illnesses, which is why it is now a part of medication discovery and research into all conditions.

Moreover, a respectable growth rate is projected for the European market during the projection period. The presence of several important manufacturers, such as Abbott, Qiagen, GE Healthcare, and BASF SE, is the main factor fueling the expansion of the customized medicine market in this area.

Additionally, Asia Pacific is predicted to be the fastest expanding segment over the course of the projection year due to rising demand for tailored diagnostics and novel treatment pharmaceuticals to counteract the region's rising disease prevalence.

Furthermore, the rest of the world's personalized medicine market is divided into the Middle East, Africa, and Latin America. The personalized medicine market in Latin America and the Middle East & Africa (MEA) region is expected to witness significant growth in the coming years. Personalized medicine refers to the tailoring of medical treatments to the individual characteristics of each patient, based on their genetic makeup, lifestyle, and environmental factors.

Key Findings of the Study

• The global personalized medicine market is expected to reach USD 970.7 billion by 2032, at a CAGR of 7.20% during the forecast period.


• The Asia Pacific region accounted for the fastest-growing global market due to Funding from significant pharmaceutical corporations and research institutions


• Based on gasifier application, the transportation segment was attributed to holding the largest market in 2022, with an approximate market share of 45–65%.


• Illumina Inc., Precision Biologics, Danaher Corporation, GE Healthcare, Celera Diagnostics LLC, Decode Genetics Inc., Exact Sciences Corporation, IBM Corporation, Exagen Inc., and Biogen